Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Myelodysplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002800
What this trial is testing

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesNeutropenia
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)UnknownNCT00022321
What this trial is testing

Gemtuzumab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01031498
What this trial is testing

Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting

Who this might be right for
Acute Myelogenous LeukemiaChemotherapy-induced Nausea and Vomiting
M.D. Anderson Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT01261312
What this trial is testing

SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Who this might be right for
MDSCMMLAML
Astex Pharmaceuticals, Inc. 414
Testing effectiveness (Phase 2)UnknownNCT03412409
What this trial is testing

RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Peking University People's Hospital 50
Early research (Phase 1)Study completedNCT00641030
What this trial is testing

Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 20
Early research (Phase 1)UnknownNCT03647800
What this trial is testing

Study of APVO436 in Patients With AML or MDS

Who this might be right for
AMLMDS
Aptevo Research and Development LLC 136
Testing effectiveness (Phase 2)Study completedNCT01567059
What this trial is testing

Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Multilineage DysplasiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+6 more
Fred Hutchinson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00004896
What this trial is testing

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT00185679
What this trial is testing

Haploid Allogeneic Transplant Using the CliniMACS System

Who this might be right for
Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk FactorsChronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic PhaseMyelodysplastic Syndrome (MDS) - High and Intermediate Risk+2 more
Ginna Laport 13
Testing effectiveness (Phase 2)Looking for participantsNCT06536959
What this trial is testing

VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS

Who this might be right for
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Beijing 302 Hospital 67
Early research (Phase 1)Study completedNCT00828802
What this trial is testing

Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Duke University 15
Testing effectiveness (Phase 2)Ended earlyNCT03946670
What this trial is testing

MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 127
Not applicableStudy completedNCT01804101
What this trial is testing

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
Fred Hutchinson Cancer Center 48
Early research (Phase 1)Study completedNCT02553941
What this trial is testing

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

Who this might be right for
Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+2 more
Brian Jonas 21
Early research (Phase 1)Looking for participantsNCT04678401
What this trial is testing

IS-free Treg HaploHCT

Who this might be right for
Stem Cell Transplant ComplicationsGraft Vs Host DiseaseMyeloid Leukemia, Acute+2 more
Dana-Farber Cancer Institute 30
Large-scale testing (Phase 3)Ended earlyNCT04313881
What this trial is testing

Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Gilead Sciences 539
Testing effectiveness (Phase 2)Study completedNCT02159872
What this trial is testing

Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 48
Early research (Phase 1)Study completedNCT02323139
What this trial is testing

LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients

Who this might be right for
MDS
Groupe Francophone des Myelodysplasies 23
Testing effectiveness (Phase 2)Looking for participantsNCT02115295
What this trial is testing

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Myeloid LeukemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+11 more
M.D. Anderson Cancer Center 508
Next Page